Clinical Trial Update: A Study of SHR-1802 in Combination With Adebrelimab in Patients With Advanced Solid Tumors [Phase 1, Phase 2]

View source ↗

Summary

A phase 1/2 study evaluating SHR-1802 in combination with adebrelimab in patients with advanced solid tumors.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumor

Drugs mentioned

• Adebrelimab (adebrelimab)
• SHR-1802

Snippet

Sponsor: Shanghai Hengrui Pharmaceutical Co., Ltd. | Conditions: Advanced Solid Tumor | Phase 1, Phase 2 | Status: UNKNOWN